Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives ; volume:38 ; number:7 ; day:3 ; month:6 ; year:2024 ; pages:507-532 ; date:7.2024
CNS drugs ; 38, Heft 7 (3.6.2024), 507-532, 7.2024
- Urheber
-
Gucký, Adrián
Hamuľaková, Slávka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-024-01093-0
- URN
-
urn:nbn:de:101:1-2408271258306.007135271893
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gucký, Adrián
- Hamuľaková, Slávka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Asymmetric organocatalyzed synthesis of coumarin derivatives
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
Alzheimer’s Disease
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Spectral properties of coumarin derivatives in various environments
Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives
Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
Alzheimer
Alzheimer
Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease
Coumarin sulfonamide derivatives: An emerging class of therapeutic agents
Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling
Asymmetric organocatalyzed synthesis of coumarin derivatives
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
Alzheimer’s Disease
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Spectral properties of coumarin derivatives in various environments
Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives
Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
Alzheimer
Alzheimer
Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease
Coumarin sulfonamide derivatives: An emerging class of therapeutic agents
Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling
Asymmetric organocatalyzed synthesis of coumarin derivatives
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
Alzheimer’s Disease
Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease
Spectral properties of coumarin derivatives in various environments
Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives
Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
Alzheimer
Alzheimer
Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease
Coumarin sulfonamide derivatives: An emerging class of therapeutic agents